Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism CASP4 modulators(caspase 4 modulators), caspase 1 modulators(Caspase-1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Degenerative disorder | Preclinical | Canada | 30 Jan 2022 | |
| Multiple Sclerosis | Preclinical | Canada | 30 Jan 2022 | |
| Alzheimer Disease | Preclinical | Canada | - | |
| Heart Diseases | Preclinical | Canada | - | |
| Inflammation | Preclinical | Canada | - |





